CEL-SCI Corporation news

   Watch this stock
Showing stories 61 - 70 of about 88   

Articles published

CVM 1.80 0.00 (0.00%)
price chart
Severe Acute Respiratory Syndrome (SARS) – analysis by stage of development ...
The Severe acute respiratory syndrome (SARS) pipeline guide also reviews of key players involved in therapeutic development for Severe acute respiratory syndrome (SARS) “3-V Biosciences Inc,Autoimmune Technologies LLC, Biotron Ltd,CEL-SCI Corp ...
CEL-SCI (NYSEMKT:CVM) Getting Critical News Coverage, Study Shows
News headlines about CEL-SCI (NYSEMKT:CVM) have been trending somewhat negative on Thursday, Accern reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time.
MENTOR CAPITAL, INC. (OTCMKTS:MNTR) Files An 8-K Other Events
... in medical marijuana and recreational use cannabis companies. The Firm has $140 million capital structure and looks like a marijuana fund or cannabis index fund.
Poxviridae Infections Drug Market Clinical Aspects, and Analysis by Experts 2018
Global Poxviridae Infections Drug Market Research Report 2018 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making.
Global Severe Acute Respiratory Syndrome Therapeutics Market 2018- CEL-SCI ...
The Report entitled Global Severe Acute Respiratory Syndrome Therapeutics Market 2018 analyses the crucial factors of the Severe Acute Respiratory Syndrome Therapeutics market based on present industry situations, market demands, business strategies ...
United States Severe Acute Respiratory Syndrome(SARS) Therapeutics Market 2017 ...
An up-to-date research has been disclosed by Questale highlighting the United States Severe Acute Respiratory Syndrome(SARS) Therapeutics segment.
EMEA (Europe, Middle East and Africa) Poxviridae Infections Drug Market ...
An up-to-date research has been disclosed by Questale highlighting the EMEA (Europe, Middle East and Africa) Poxviridae Infections Drug segment.
West Nile Virus Infections Medicine Market Global Briefing 2018 to 2025
This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability.
Global Poxviridae Infections Drug Market : Top Manufacturers, Market Growth ...
The information on trends and developments, focuses on markets and materials, capacities, technologies, CAPEX cycle and the changing structure of the Global Poxviridae Infections Drug Market.
Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market 2017 ...
In addition to this, the research includes historical data of 5 previous years pertaining to company profiles of key players/manufacturers in the industry such as CEL-SCI Corporation , GeneCure LLC , Humabs BioMed SA . The in-depth information by ...